These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6969360)

  • 21. [New knowledge on immunology in gynecologic cancer].
    Kreienberg R
    Arch Gynecol Obstet; 1987; 242(1-4):215-26. PubMed ID: 3318719
    [No Abstract]   [Full Text] [Related]  

  • 22. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
    Flynn MK; Johnston W; Bigner S
    Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of tolerance against human chorionic gonadotropin at malignant and benign tumors of female reproduction system.
    Akhvlediani L; Nagervadze M; Dumbadze G
    Georgian Med News; 2009 Jun; (171):20-4. PubMed ID: 19578206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [1st experiences with the "cancer-serum-index" in gynecologic malignancies].
    Szalay S; Tatra G; Janisch H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():142-3. PubMed ID: 7194261
    [No Abstract]   [Full Text] [Related]  

  • 25. Introduction: methodology for detection of antigens in preneoplastic and neoplastic tissues.
    Borsos T
    Natl Cancer Inst Monogr; 1972 Dec; 35():3-4. PubMed ID: 4659053
    [No Abstract]   [Full Text] [Related]  

  • 26. [Activity of alkaline phosphatase and Regan's isoenzyme in blood serum samples collected from women with malignant neoplasms, benign neoplasms, inflammatory conditions of the genitalia and from healthy subjects].
    Kaczmarczyk H; Kasperczyk W; Gonsior B; Wodarczyk-Matysek D
    Ginekol Pol; 1978 Jan; 49(1):29-33. PubMed ID: 640479
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiodiagnostic and radiotherapeutic implications of the recent discovery of a common malignant tumour antigen, CTA, absolutely unique to cancer cells.
    Kast RE
    Radiobiol Radiother (Berl); 1977; 18(4):536-44. PubMed ID: 601218
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biomarker in gynecologic malignancies].
    Isonishi S
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delays in diagnosis and stage of disease in gynecologic cancer.
    Fruchter RG; Boyce J
    Cancer Detect Prev; 1981; 4(1-4):481-6. PubMed ID: 7349814
    [No Abstract]   [Full Text] [Related]  

  • 30. Photomedical approaches for the diagnosis and treatment of gynecologic cancers.
    Hornung R
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):165-77. PubMed ID: 12476797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Definition of immune status in patients with malignant gynecologic neoplasms].
    Koenig UD
    Arch Gynecol; 1979 Jul; 228(1-4):604-5. PubMed ID: 485501
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for gynecologic malignancies: A continuing responsibility.
    Runowicz CD; Fields AL
    Surg Oncol Clin N Am; 1999 Oct; 8(4):703-23, vii. PubMed ID: 10452936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The secretion of ABH group substances by women with gynecologic carcinomas].
    Milunicová A; Jandová A; Skoda V
    Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 139(1):90-3. PubMed ID: 4239411
    [No Abstract]   [Full Text] [Related]  

  • 35. Surgical staging of gynecologic malignancies: the role of laparoscopy and sentinel node technology.
    Kim R; Rose PG
    Surg Oncol Clin N Am; 2005 Apr; 14(2):267-88. PubMed ID: 15817239
    [No Abstract]   [Full Text] [Related]  

  • 36. Gynecologic malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1994; 15():555-80. PubMed ID: 7779599
    [No Abstract]   [Full Text] [Related]  

  • 37. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
    Carico E; Chicchirichi R; Atlante M; Giovagnoli M; Vecchione A
    Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunologic technics for cancer detection].
    Herrera-Tinajero L
    Gac Med Mex; 1982 Jan; 118(1):21-3. PubMed ID: 7084575
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiation therapy for gynecologic malignancies.
    Bradley KA; Petereit DG
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):347-61. PubMed ID: 16730298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor antibodies in ovarian cancer.
    Luborsky JL; Barua A; Shatavi SV; Kebede T; Abramowicz J; Rotmensch J
    Am J Reprod Immunol; 2005 Aug; 54(2):55-62. PubMed ID: 16105096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.